Names Sequences

Xoo3988-in-F GCTGGCGGTGACGTTTATTG
Xoo3988-in-R CGCATGTTTCTTGAGGTCGC
Xoo3989-in-F GGACGATGCGTACCACTTCA
Xoo3989-in-R CGGCTTGGCTTTTTCGAAGG
Xoo3988-3989-F CCACGCTCAAGCTCAATCAA
Xoo3988-3989-R CGACTGGCTGAACATGAAAGG
dgcA-up-F CGAATTCTCACCGATAAAGATGCCG
dgcA-up-R GAGGATCCGGCGTACAAGCGCAT
dgcA-down-F CCCGGTCGACCATCAGGTGACCT
dgcA-down-R GTCAAGCTTACCGGCGCCAAGGC
Gm-F GCGGATCCCCAGTTGACATAAGC
Gm-R GAACGTCGACTTAGGTGGCGGTAC
dgcA-F2 AGGGATCCATGCGCTTGTACGCCGGAC
dgcA-R2 GGATCCTCAGTGGTGGTGGTGGTGGTGGGTCACCTGATGACCGCGCG
M13-F TGTAAAACGACGGCCAGT
M13-R CAGGAAACAGCTATGACC
Kan-F ATGATTGAACAAGATGGATTGCACG Kan-R TCAGAAGAACTCGTCAAGAAGGC Table S3 . Key primers used in this study. Forward (F) and reverse (R) primers are listed from 5' to 3'. The restriction sites are underlined.
